Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women

Preventive Medicine

Volumn 64, Issue , 2014, Pages 108-113

  Bosgraaf, Remko P ^a   Ketelaars, Pleun J W ^a   Verhoef, Viola M J ^b   Massuger, Leon F A G ^a   Meijer, Chris J L M ^b   Melchers, Willem J G ^a   Bekkers, Ruud L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Early detection of cancer; HPV self sampling; Non attendance; Questionnaires; Screening; Uterine cervical neoplasms

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CANCER PREVENTION; CANCER SCREENING; CERVICOVAGINAL SELF-SAMPLING DEVICE; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CONCEPT; SELF CONTROL; UTERINE CERVIX CYTOLOGY; WART VIRUS; AGE DISTRIBUTION; CONTROLLED STUDY; EARLY DIAGNOSIS; LABORATORY DIAGNOSIS; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; PATIENT PREFERENCE; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SELF CARE; STATISTICS AND NUMERICAL DATA; TIME; VAGINA SMEAR; WOMEN'S HEALTH;

ADULT; AGE DISTRIBUTION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; NETHERLANDS; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PREFERENCE; QUESTIONNAIRES; SELF CARE; SPECIMEN HANDLING; TIME FACTORS; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 84899861408     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.04.011     Document Type: Article

References (36)

1. Anttila A., von Karsa L., Aasmaa A., et al. Cervical cancer screening policies and coverage in Europe. Eur. J. Cancer 2009, 45:2649-2658.
2. Arbyn M., Anttila A., Jordan J., et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document. Ann. Oncol.: ESMO 2010, 21:448-458.
3. Arbyn M., de Sanjose S., Saraiya M., et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int. J. Cancer 2012, 131:1969-1982.
4. Arbyn M., Verdoodt F., Snijders P.J., et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014, 15:172-183.
5. Austoker J. Cancer prevention in primary care. Screening for cervical cancer. BMJ 1994, 309:241-248.
6. Bais A.G., van Kemenade F.J., Berkhof J., et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int. J. Cancer 2007, 120:1505-1510.
7. Bekkers R.L., Meijer C.J., Massuger L.F., Snijders P.J., Melchers W.J. Effects of HPV detection in population-based screening programmes for cervical cancer; a Dutch moment. Gynecol. Oncol. 2006, 100:451-454.
8. Berkers L.M., van Ballegooijen M., van Kemenade F.J., et al. The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening. NTvG 2007, 151:1288-1294.
9. Bosgraaf R.P., Mast P.P., Struik-van der Zanden P.H., Bulten J., Massuger L.F., Bekkers R.L. Overtreatment in a see-and-treat approach to cervical intraepithelial lesions. Obstet. Gynecol. 2013, 121:1209-1216.
10. Bosgraaf R.P., Siebers A.G., De Hullu J.A., et al. The current position and the future perspectives of cervical cancer screening. Expert. Rev. Anticancer. Ther. 2014, 14:75-92.
11. Braspenning J., Tacken M., Penders A., Van den Hoogen H., de Bakker D. Opkomst bevolkingsonderzoek baarmoederhalskanker, 1997-1999. TSG 2001, 79:341-345.
12. Broberg G., Jonasson J.M., Ellis J., et al. Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial. Int. J. Cancer 2013, 133:164-171.
13. de Kok I.M., van der Aa M.A., van Ballegooijen M., et al. Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?. Int. J. Cancer 2011, 128:2174-2181.
14. Giorgi Rossi P., Marsili L.M., Camilloni L., et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Brit. J. Cancer 2011, 104:248-254.
15. Gok M., Heideman D.A., van Kemenade F.J., et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010, 340:c1040.
16. Gok M., van Kemenade F.J., Heideman D.A., et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int. J. Cancer 2012, 130:1128-1135.
17. Gravitt P.E., Belinson J.L., Salmeron J., Shah K.V. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int. J. Cancer 2011, 129:517-527.
18. Jepson R., Clegg A., Forbes C., Lewis R., Sowden A., Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol. Assess. 2000, 4(i-vii):1-133.
19. Knops-Dullens T., de Vries N., de Vries H. Reasons for non-attendance in cervical cancer screening programmes: an application of the Integrated Model for Behavioural Change. Eur. J. Cancer Prev. 2007, 16:436-445.
20. Kuiper D., Holwerda A., Dijkstra G. Non-respons bij bevolkingsonderzoek naar baarmoederhalskanker 2005, Noordelijk Centrum voor Gezondheidsvraagstukken, sectie Toegepast Onderzoek, Groningen.
21. Meijer C.J., Berkhof J., Castle P.E., et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30years and older. Int. J. Cancer 2009, 124:516-520.
22. Ministry of Health, Welfare and Sport Letter to the House of Representatives of the Dutch parliament: improvement of the Dutch cervical cancer screening 2013.
23. Peto J., Gilham C., Fletcher O., Matthews F.E. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004, 364:249-256.
24. Petry K.U., Menton S., Menton M., et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29years in Germany: results for 8466 patients. Brit. J. Cancer 2003, 88:1570-1577.
25. Rebolj M., van Ballegooijen M., Berkers L.M., Habbema D. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int. J. Cancer 2007, 120:806-812.
26. Rijkaart D.C., Berkhof J., Rozendaal L., et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 2012, 13:78-88.
27. Ronco G., Giorgi-Rossi P., Carozzi F., et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010, 11:249-257.
28. Sasieni P., Adams J., Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Brit. J. Cancer 2003, 89:88-93.
29. Schmeink C.E., Bekkers R.L., Massuger L.F., Melchers W.J. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev. Med. Virol. 2011, 21:139-153.
30. Segnan N., Senore C., Giordano L., Ponti A., Ronco G. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Tumori 1998, 84:348-353.
31. Snijders P.J., Verhoef V.M., Arbyn M., et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int. J. Cancer 2013, 132:2223-2236.
32. Szarewski A., Cadman L., Ashdown-Barr L., Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J. Med. Screen. 2009, 16:193-198.
33. Verhoef V.M., Bosgraaf R.P., van Kemenade F.J., et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlles non-inferiority trial. Lancet Oncol. 2014, 15:315-322.
34. Virtanen A., Nieminen P., Luostarinen T., Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1960-1969.
35. Waller J., Bartoszek M., Marlow L., Wardle J. Barriers to cervical cancer screening attendance in England: a population-based survey. J. Med. Screen. 2009, 16:199-204.
36. Wikstrom I., Lindell M., Sanner K., Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Brit. J. Cancer 2011, 105:337-339.